Omeros (OMER) Other Working Capital Changes (2010 - 2026)
Omeros (OMER) posted Other Working Capital Changes of $262000.0 for Q3 2014, little changed sequentially from $262000.0 in Q2 2014, and down 74.46% YoY from $1.0 million in Q3 2013.
Analysis
Omeros (OMER) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Omeros has reported Other Working Capital Changes for 3 years, with the latest figure at $262000.0 in Q3 2014.
- Quarterly Other Working Capital Changes fell 74.46% year-over-year to $262000.0 in Q3 2014, while the trailing twelve-month figure through Sep 2014 was $1.8 million (down 40.93% YoY) and the FY2021 annual result came in at $668000.0, changed N/A from the prior year.
- Other Working Capital Changes steadied at $262000.0 in Q3 2014 per OMER's latest filing, from $262000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $5.1 million in Q1 2024 and troughed at -$7.0 million in Q2 2024.
- A 5-year average of $161823.5 and a median of $462000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 3703.85% in 2013, down 97.16% in 2013.
- Over 3 years, Other Working Capital Changes stood at $82000.0 in 2012, then jumped by 1151.22% to $1.0 million in 2013, then tumbled by 74.46% to $262000.0 in 2014.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $262000.0, $262000.0, and $263000.0 for Q3 2014, Q2 2014, and Q1 2014 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.65 Mn |
| Jun 30, 2026 | -1.65 Mn |
| Mar 31, 2026 | -87,000.00 |
| Mar 31, 2026 | -87,000.00 |
| Dec 31, 2025 | 4.02 Mn |
| Dec 31, 2025 | 4.02 Mn |
| Sep 30, 2025 | -2.40 Mn |
| Sep 30, 2025 | -2.40 Mn |
| Jun 30, 2025 | -787,000.00 |
| Jun 30, 2025 | -787,000.00 |
| Mar 31, 2025 | 472,000.00 |
| Mar 31, 2025 | 472,000.00 |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 188,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | -6.98 Mn |
| Jun 30, 2024 | -6.98 Mn |
| Mar 31, 2024 | 5.09 Mn |
| Mar 31, 2024 | 5.09 Mn |